Some visit links earn us a commission.
Quick verdict
Hims & Hers is the better pick for most patients on overall scoring. Same-day prescription, no lock-in and brand-name confidence. Hims pivoted to branded-only in March 2026 after settling with Novo Nordisk; compounded semaglutide is closed to new patients. Headline price is $299/mo branded Wegovy injectable (self-pay), plus $149/mo membership.
That said, Eden wins on specific dimensions. Eden is the highest-volume compounded-only brand outside Henry. Slick funnel, low intro pricing, lots of upsell. Quality of clinical experience is thinner than Henry or Ivim and cancellation is the most common complaint thread.
Side-by-side
| Hims & Hers | Eden | |
|---|---|---|
| Starts from | $299/mo (incl. medication) | $209/mo (incl. medication) |
| Monthly cost gap | Eden is $90/mo cheaper than Hims & Hers | |
| Lock-in | Month-to-month | 3-mo minimum |
| Time to prescription | 1 day | 2 days |
| Consultation type | Asynchronous | Asynchronous |
| Affiliate network | Impact | Impact |
Score by dimension
Scores out of 10, equal-weighted across five dimensions. How we score. The winner of each dimension is highlighted.
| Hims & Hers | Eden | |
|---|---|---|
| Pricing transparency | 6/10 | 7/10 |
| Cancellation terms | 9/10 | 5/10 |
| Onboarding experience | 9/10 | 8/10 |
| Medication options | 5/10 | 5/10 |
| Member reviews | 6/10 | 9/10 |
When to choose Hims & Hers
Best for fast async onboarding
Patients who want a fast, low-friction async path to a branded GLP-1 prescription with predictable monthly pricing.
Hims & Hers wins on cancellation terms, onboarding experience on the dimensional scoring. The caveat: Patients who wanted Hims's old compounded semaglutide tier or who need insurance-routed branded access. Compounded is closed to new patients. Note also: Settled with Novo Nordisk March 9, 2026 over compounded semaglutide marketing
When to choose Eden
Best for lowest sticker price
Price-led buyers willing to navigate a heavier upsell flow for an aggressive intro price.
Eden wins on pricing transparency, member reviews and runs $90/mo cheaper than Hims & Hers at the entry tier ($209 vs $299). Over a year that's $1,080 you keep. The caveat: Anyone who values transparent recurring billing or branded medication. Note also: Compounded oral troches are a personalization-claim formulation with thin clinical evidence base.
If cost is your main filter
Eden is the cheaper monthly: $209 all-in vs $299 for Hims & Hers. That's $90 a month or $1,080a year. The 12-month math matters most if you're planning to maintain on GLP-1 long-term. If you're running a 3-month trial, the $270 delta is small against the cost of stopping early on the wrong dose. Insurance changes the picture: if either program runs prior auth and your plan covers Wegovy or Zepbound, branded with copay can beat both cash-pay totals.
If lock-in is your main filter
Hims & Hers (month-to-month) and Eden (3-mo minimum) sit at different cancellation tiers. If you're first-time on a GLP-1 and unsure how you'll tolerate it, Hims & Hers's easier cancellation is the safer trial.
FAQ
Is Hims & Hers cheaper than Eden?
Can I switch from Hims & Hers to Eden mid-treatment?
Which program has better member feedback?
Read the full reviews
All head-to-head comparisons → · Full chart → · Cost guide · Programs guide
